We engineered a nano-Fc antibody coding sequence against VEGFR2.
The construct transfected to NS0 host cell line and stable clones were selected by Zeocin selection medium.
The supernatant collected and purified by protein A chromatography.
Western blot and ELISA test confirmed the fusionbody's presence on purified sample.
Flowcytometry analysis demonstrated the fusionbody's function in in vitro steps.